Celsius (NASDAQ:CELH) PT Raised to $120.00

Celsius (NASDAQ:CELHGet Rating) had its price objective upped by research analysts at LADENBURG THALM/SH SH from $113.50 to $120.00 in a report released on Wednesday, The Fly reports. LADENBURG THALM/SH SH’s target price suggests a potential upside of 190.49% from the stock’s previous close.

Several other equities research analysts have also issued reports on CELH. Credit Suisse Group dropped their price objective on shares of Celsius from $103.00 to $50.00 in a research report on Wednesday, January 26th. Maxim Group upgraded shares of Celsius from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research note on Wednesday. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $98.63.

CELH stock opened at $41.31 on Wednesday. The stock has a market capitalization of $3.11 billion, a P/E ratio of 172.13 and a beta of 1.95. Celsius has a 52 week low of $38.31 and a 52 week high of $110.22. The business’s 50-day moving average is $53.58.

Celsius (NASDAQ:CELHGet Rating) last announced its quarterly earnings results on Tuesday, May 10th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.06. The company had revenue of $133.39 million for the quarter, compared to the consensus estimate of $114.27 million. Celsius had a net margin of 6.12% and a return on equity of 10.83%. The company’s revenue for the quarter was up 166.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.01 earnings per share. As a group, analysts predict that Celsius will post 0.28 EPS for the current year.

In related news, major shareholder William H. Milmoe sold 20,000 shares of the stock in a transaction dated Tuesday, March 29th. The shares were sold at an average price of $60.04, for a total value of $1,200,800.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 13.19% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Sawtooth Solutions LLC increased its stake in Celsius by 2.3% during the 3rd quarter. Sawtooth Solutions LLC now owns 4,672 shares of the company’s stock valued at $421,000 after buying an additional 104 shares during the period. Captrust Financial Advisors increased its stake in Celsius by 13.5% during the 3rd quarter. Captrust Financial Advisors now owns 1,352 shares of the company’s stock valued at $122,000 after buying an additional 161 shares during the period. Profund Advisors LLC increased its stake in Celsius by 4.8% during the 3rd quarter. Profund Advisors LLC now owns 4,143 shares of the company’s stock valued at $373,000 after buying an additional 190 shares during the period. CIBC Asset Management Inc increased its stake in Celsius by 9.3% during the 3rd quarter. CIBC Asset Management Inc now owns 2,959 shares of the company’s stock valued at $267,000 after buying an additional 251 shares during the period. Finally, US Bancorp DE increased its stake in Celsius by 64.8% during the 3rd quarter. US Bancorp DE now owns 651 shares of the company’s stock valued at $59,000 after buying an additional 256 shares during the period. 45.59% of the stock is currently owned by hedge funds and other institutional investors.

Celsius Company Profile (Get Rating)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. It offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name.

Further Reading

The Fly logo

Analyst Recommendations for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.